American Cancer Society Responds to FDA Decision on Avastin
WASHINGTON -- The Food and Drug Administration (FDA) announced today that it has revoked its approval of Avastin for metastatic breast cancer after concluding that the drug "has not been shown to be safe and effective for that use." The drug will remain an approved treatment for certain types of